Tapderimotide

Tapderimotide (hTERT (691–705) ) is a peptide-based immunogen designed for active immunization research. It is applied in immunological studies targeting telomerase, with utility in both in vitro T-cell stimulation assays and in vivo cancer vaccine development models to investigate anti-tumor immune responses.